On May 19, 2022, Ms. Alessandra Daigneault tendered her resignation as Chief Corporate Officer, General Counsel and Corporate Secretary of NRx Pharmaceuticals, Inc. effective on July 18, 2022 or such earlier date as may be agreed with the Company. Ms. Daigneault is leaving the company to pursue other personal and professional interests. Mr. Michael Kunz, the Company's Deputy General Counsel, is expected to assume the duties of General Counsel and Corporate Secretary.

On May 19, 2022, Mr. Ira Strassberg tendered his resignation as Treasurer of the Company effective July 18, 2022. Mr. Strassberg is leaving the Company to pursue other personal and professional interests. Mr. Strassberg will continue to fulfill his duties as Treasurer of the Company until his departure.

The Board will be conducting a search for a successor.